1. Home
  2. ALVO vs SLBT Comparison

ALVO vs SLBT Comparison

Compare ALVO & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$5.85

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$1.53

Market Cap

942.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ALVO
SLBT
Founded
2013
N/A
Country
Luxembourg
Taiwan
Employees
N/A
20
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
942.1M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
ALVO
SLBT
Price
$5.85
$1.53
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $8.00
N/A
AVG Volume (30 Days)
★ 972.6K
79.0K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.28
N/A
Revenue Next Year
$18.63
N/A
P/E Ratio
$18.20
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.94
$1.50
52 Week High
$9.05
$6.25

Technical Indicators

Market Signals
Indicator
ALVO
SLBT
Relative Strength Index (RSI) 72.69 26.81
Support Level $3.10 N/A
Resistance Level N/A $3.36
Average True Range (ATR) 0.26 0.22
MACD 0.02 -0.04
Stochastic Oscillator 81.47 9.21

Price Performance

Historical Comparison
ALVO
SLBT

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Share on Social Networks: